tiprankstipranks
Trending News
More News >
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Germany Market

Vicore Pharma Holding AB (6Y4) Financial Statements

Compare
2 Followers

Vicore Pharma Holding AB Financial Overview

Vicore Pharma Holding AB's market cap is currently €135.64M. The company's EPS TTM is €-0.098; its P/E ratio is ―; Vicore Pharma Holding AB is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is €-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 109.35Mkr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr 109.35Mkr -3.42Mkr -3.61Mkr -3.60Mkr -3.54M
Operating Incomekr -194.19Mkr -321.51Mkr -290.73Mkr -294.82Mkr -149.54M
EBITDAkr -168.88Mkr -317.47Mkr -286.20Mkr -293.13Mkr -143.77M
Net Incomekr -168.63Mkr -310.94Mkr -288.42Mkr -296.48Mkr -146.86M
Balance Sheet
Cash & Short-Term Investmentskr 1.16Bkr 482.77Mkr 261.74Mkr 371.20Mkr 318.62M
Total Assetskr 1.20Bkr 497.84Mkr 338.01Mkr 451.17Mkr 406.51M
Total Debtkr 0.00kr 0.00kr 65.00Kkr 320.00Kkr 140.00K
Net Debtkr -1.16Bkr -333.62Mkr -256.74Mkr -293.88Mkr -248.48M
Total Liabilitieskr 73.78Mkr 42.45Mkr 48.92Mkr 67.85Mkr 52.00M
Stockholders' Equitykr 1.13Bkr 455.39Mkr 289.08Mkr 383.32Mkr 354.51M
Cash Flow
Free Cash Flowkr -164.95Mkr -448.62Mkr -302.92Mkr -265.17Mkr -122.94M
Operating Cash Flowkr -164.95Mkr -249.58Mkr -299.92Mkr -265.17Mkr -119.94M
Investing Cash Flowkr 149.04Mkr -144.46Mkr 74.00Mkr -7.00Mkr 4.00M
Financing Cash Flowkr 834.06Mkr 470.86Mkr 187.04Mkr 318.18Mkr 176.97M
Currency in SEK

Vicore Pharma Holding AB Earnings and Revenue History

Vicore Pharma Holding AB Debt to Assets

Vicore Pharma Holding AB Cash Flow

Vicore Pharma Holding AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis